Emcure Group firm Gennova Biopharmaceuticals, which is developing India’s first mRNA-based Covid-19 vaccine, is set to start recruitment for phase 1 clinical trials in a week. Vikas Thapar, president — corporate development & strategy — Emcure Group, told Business Standard that the firm was readying for clinical trials anytime now. “We got the final nod from the regulator last week to start phase 1 clinical trials. We are going to start it anytime now.

Leave a Reply

Your email address will not be published. Required fields are marked *